Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis
Overview
One useful effect of early intravitreal corticotherapy is to diminish inflammatory complications after endophthalmitis, which may cause, at least in part, serious complications (retinal detachment, macular edema) which are, more than the infection, causes of the complications seen after acute endophthalmitis.
Full Title of Study: “Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Single (Participant)
- Study Primary Completion Date: October 2014
Interventions
- Procedure: Intravitreal injection of Betamethasone + antibiotics
- Procedure: Intravitreal injection of antibiotics
Arms, Groups and Cohorts
- Experimental: with corticoids
- Other: without corticoids
Clinical Trial Outcome Measures
Primary Measures
- Measure the evolution of visual acuity
- Time Frame: up to12 months
Participating in This Clinical Trial
Inclusion Criteria
- All patients male or female with no age limit – Hospitalized for the diagnosis and treatment of acute endophthalmitis following cataract surgery – Who had given their consent after being informed about intravitreal corticotherapy Exclusion Criteria:
- Patients who refused or were unable to give their consent – Prior intravitreal corticotherapy
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.